AAA Endovascular Graft Patient Imaging Follow-Up Recommended By FDA
This article was originally published in The Gray Sheet
Executive Summary
The Center for Devices and Radiological Health is considering a postmarket surveillance study for abdominal aortic aneurysm devices under Sec. 522 of the Safe Medical Devices Act.
You may also be interested in...
FDA Notice Updates Medtronic AneuRx AAA-Related Death Statistics
Physician or institutional experience should be considered in determining whether to treat a AAA with a Medtronic AneuRx endovascular stent or open surgery, according to a 1Dec. 17 FDA public health notice
FDA Notice Updates Medtronic AneuRx AAA-Related Death Statistics
Physician or institutional experience should be considered in determining whether to treat a AAA with a Medtronic AneuRx endovascular stent or open surgery, according to a 1Dec. 17 FDA public health notice
AneuRx Is First Sec. 522 Study Ordered Under Proposed Rule; More To Follow
Medtronic's AneuRx abdominal aortic aneurysm (AAA) endovascular graft will aim to compare long-term outcomes of the device's IDE cohort with patients who received the implant postmarket.